Aurinia Pharmaceuticals Inc (AUPH)

NASDAQ
7.49
-0.01(-0.20%)
  • Volume:
    1,165,676
  • Day's Range:
    7.37 - 7.62
  • 52 wk Range:
    6.29 - 33.97

AUPH Overview

Prev. Close
7.5
Day's Range
7.37-7.62
Revenue
66.31M
Open
7.38
52 wk Range
6.29-33.97
EPS
-1.15
Volume
1,165,676
Market Cap
1.06B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,363,850
P/E Ratio
-7.11
Beta
0.942
1-Year Change
-64.44%
Shares Outstanding
141,892,181
Next Earnings Date
Nov 15, 2022
What is your sentiment on Aurinia Pharma?
or
Vote to see community's results!

Aurinia Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Aurinia Pharmaceuticals Inc Analysis

Aurinia Pharmaceuticals Inc Company Profile

Aurinia Pharmaceuticals Inc Company Profile

Employees
300

Aurinia Pharmaceuticals Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases. The Company has developed LUPKYNISTM, for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct pre-clinical, clinical, and regulatory advancement to support the voclosporin development program. LUPKYNIS is a calcineurin inhibitor (CNI) immunosuppressant, that improves near and long-term outcomes in LN when used in combination with mycophenolate mofetil and steroids. LUPKYNIS reduces cytokine activation and blocks interleukin IL-2 expression and T-cell mediated immune responses. Voclosporin, the active ingredient in LUPKYNIS, is made by a modification of a single amino acid of the cyclosporine molecule. It also focuses on treatment of autoimmune, fibrotic, and kidney-related diseases. Its product pipeline includes AUR200, AUR300.

Read More

Analyst Price Target

Average21.31 (+184.51% Upside)
High30
Low13
Price7.49
No. of Analysts7
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyBuyStrong SellBuyStrong Sell
SummaryStrong BuyStrong BuyNeutralNeutralStrong Sell
  • Get past 1801 and she could go.
    0
    • Looking for 12.8
      1
      • Offering??
        0
        • Back in for some at 2.7
          0
          • I sold out yesterday right before close. Will get back in early January. Technicals look too choppy.
            0
            • Let's fill the gap before year end.
              0
              • Very interesting Jan call volume.
                0
                • ya, this board and $sabs board dead on this site :)
                  0
                  • GSK Chatter. What does that mean?
                    0
                    • Ok, asked a friend since this board seems dead. Rumors nothing more than that. Been down this rodeo before. Holding regardless of buyout or GIA. Solid opportunity to double from here IMO.
                      0
                  • Nice volume!!
                    0